Table 3.
Reference | Number of cases | Mean age (year) | NVD | PUV | Fold increase in BC | |
---|---|---|---|---|---|---|
Gonzalez et al. (12) | 16 | 11.7 | 14 | 2 | 2.4 | |
Lima et al. (13) | 10 | 10.4 | 9 | 2.49 | Did not measure safe BC but maximal BC | |
Dewan (78) | 6 | 6 | 2.9 | |||
Dayanç et al. (76) | 10 | 13 | 10 | 3.8 | ||
Jednak et al. (66) | 28 | 11.1 | 28 | 2.4 | ||
González et al. (52) | 27 | 11 | 27 | 2.36 | All had AUS | |
González et al. (50) | 16 | 9 | 16 | 1.83 | Without concomitant bladder procedures | |
Jung et al. (77) | 34 | 10 | 2.96 | |||
Total | 147 | 2.64 |
PUVs, posterior urethral valves; NVD, neurogenic bladder dysfunction; BE, bladder exstrophy; BC, bladder capacity.